SCHEMBL15519560

SCHEMBL15519560

C=CC(CC(=O)O)O[Si](C)(C)C(C)(C)C

nearest known ligand 0.32

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
BLM P54132 1/20 0.32
SLC6A3 Q01959 1/20 0.32
MEN1 O00255 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
NFKB1 P19838 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
PGD P52209 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15519559 1.00 SLC6A2 (0.32) SLC6A2SLC6A4BLMSLC6A3MEN1
SCHEMBL30999485 0.85 ALDH1A1 (0.32) TSHR
SCHEMBL12252983 0.82 HDAC3 (0.36) CYP2D6
SCHEMBL16716801 0.82 HDAC3 (0.36) CYP2D6
SCHEMBL10159204 0.82 HDAC3 (0.36) CYP2D6
SCHEMBL27200152 0.82 SLC6A2 (0.31) SLC6A2SLC6A4BLMSLC6A3MEN1
SCHEMBL30999475 0.81 DRD2 (0.34) TSHR
SCHEMBL6118646 0.81 DRD2 (0.34) TSHR
SCHEMBL30999489 0.79
SCHEMBL2167925 0.77 ABCC4 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9809566-B2 Organocatalytic process for asymmetric synthesis of decanolides COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-11-07 US disclosed
US-9765048-B2 Organocatalytic process for asymmetric synthesis of decanolides COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-09-19 US disclosed
US-9765048-B2 Organocatalytic process for asymmetric synthesis of decanolides COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2017-09-19 US disclosed
US-20160272608-A1 ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-09-22 US disclosed
US-20160272608-A1 ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-09-22 US disclosed
US-20160272609-A1 ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-09-22 US disclosed
US-9353077-B2 Organocatalytic process for asymmetric synthesis of decanolides COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2016-05-31 US disclosed
US-20150210665-A1 ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2015-07-30 US disclosed
WO-2014037964-A2 ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2014-03-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160272609-A1 ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES CDC14A, CDC14B, DDOST SLC6A2 1147/4885SLC6A4 400/4885BLM 2528/4885
US-20150210665-A1 ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES CDC14A, CDC14B, DDOST SLC6A2 1147/4885SLC6A4 400/4885BLM 2528/4885
US-20160272608-A1 ORGANOCATALYTIC PROCESS FOR ASYMMETRIC SYNTHESIS OF DECANOLIDES CDC14A, CDC14B, DDOST SLC6A2 1147/4885SLC6A4 400/4885BLM 2528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.